FDA Approval of Daraxonrasib Marks Turning Point in Pancreatic Cancer Care
Sylvester Comprehensive Cancer Center researchers report an FDA approval for a pancreatic cancer pill that nearly doubled survival, alongside new ...
Sylvester Comprehensive Cancer Center researchers report an FDA approval for a pancreatic cancer pill that nearly doubled survival, alongside new ...
A pooled analysis of four clinical trials finds that liver metastases are a strong negative prognostic factor for chemotherapy-treated pancreatic ...
A Turkish research team reports that Quercus pyrenaica honey significantly reduced precancerous pancreatic lesions in rats both when given preventively ...
A 20-year analysis of national cancer registry data finds localized pancreatic cancer diagnoses rising sharply, especially after 2015, though disparities ...
NIH has awarded its Director's Pioneer Award to Sylvester Comprehensive Cancer Center virologist Leor Weinberger for developing an evolving oncolytic ...
University of Oklahoma researchers have identified three adjacent cell subclusters in pancreatic tumors that form a feed-forward network driving cancer ...
A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...
Researchers have combined patient-derived pancreatic tumor organoids with a deep learning algorithm called OrganoIDNet to automatically track in real time ...
A 33-year Global Burden of Disease analysis shows pancreatic cancer cases rising in both China and the United States, with ...
A new integrated study finds the gut bacterium Veillonella enriched in advanced pancreatic cancer patients and provides functional and genetic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine